康休(CXO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CXO 康休

退市 04-25 04:39:06 EDT

65.60

+0.00

0.00%

最高65.60	最低65.60	成交量0.00
今开65.60	昨收65.60	日振幅0.00%
总市值127.60亿	流通市值126.27亿	总股本1.95亿
成交额0.00	换手率0.00%	流通股本1.92亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CXO","market":"US","secType":"STK","nameCN":"康休","latestPrice":65.6,"timestamp":1610744400000,"preClose":65.6,"halted":4,"volume":0,"delay":0,"floatShares":192489259,"shares":194506801,"eps":-52.266872,"marketStatus":"退市","marketStatusCode":1,"change":0,"latestTime":"04-25 04:39:06 EDT","open":65.6,"high":65.6,"low":65.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-52.266872,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714051800000},"adr":0,"listingDate":1186113600000,"adjPreClose":65.6,"adrRate":0,"dividendRate":0.011052,"volumeRatio":0},"requestUrl":"/m/hq/s/CXO","defaultTab":"news","newsList":[{"id":"2429918661","title":"百亿基金经理如何看市场焦点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2429918661","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2429918661?lang=zh_cn&edition=full","pubTime":"2024-04-23 07:59","pubTimestamp":1713830352,"startTime":"0","endTime":"0","summary":"易方达张坤认为，从长期国债和类债的股票资产表现来看，市场的风险偏好已经降低到了很低的水平，具体表现为在定价时给予静态的股息率水平很高的权重，对成长性特别是企业的长期成长性持怀疑的态度。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/d9693536-1637-455f-8a27-5115dd0aaed5.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/d9693536-1637-455f-8a27-5115dd0aaed5.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3713331","is_publish_highlight":false,"gpt_icon":0},{"id":"2427799046","title":"沪深三大板块IPO标准迎新：超40家在审项目面临考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2427799046","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2427799046?lang=zh_cn&edition=full","pubTime":"2024-04-13 10:43","pubTimestamp":1712976188,"startTime":"0","endTime":"0","summary":"业绩踩线难言乐观","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/content_default_8.jpg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/content_default_8.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3712638","is_publish_highlight":false,"gpt_icon":0},{"id":"2426482818","title":"多家CXO公司去年营收增速放缓，行业回暖仍在路上","url":"https://stock-news.laohu8.com/highlight/detail?id=2426482818","media":"36氪","top":-1,"share":"https://www.laohu8.com/m/news/2426482818?lang=zh_cn&edition=full","pubTime":"2024-04-10 08:25","pubTimestamp":1712708720,"startTime":"0","endTime":"0","summary":"从公布的数据来看，多家CXO公司的营业收入增速相比以往出现下滑，且存在较为明显的分化。头豹研究院分析师谭志坚表示，CXO公司的业绩根基在于医药研发生产的持续投入。自2023年开始，行业投融资大环境降温，药企纷纷收缩研发管线，导致CXO企业整体订单数量下滑明显。对于行业是否回暖，每家企业的“体感温度”并不相同。有...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240410A015FR00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240410A015FR00","is_publish_highlight":false,"gpt_icon":0},{"id":"2426415834","title":"港股CXO迎集体降速时刻，下行周期何时结束？","url":"https://stock-news.laohu8.com/highlight/detail?id=2426415834","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426415834?lang=zh_cn&edition=full","pubTime":"2024-04-09 15:33","pubTimestamp":1712648021,"startTime":"0","endTime":"0","summary":"消息传出后，早已是“惊弓之鸟”的港股CXO板块集体下挫。CXO下行周期中的业绩分化虽然2023年国内CXO板块集体承压，但作为港股CXO板块的四大头部企业，康龙化成、昭衍新药、凯莱英、泰格医药在2023年的业绩表现却分化明显。而凯莱英当期营收为78.25亿元，同比下降23.70%;归母净利润为22.69亿元，同比下降31.28%。虽说全球CXO板块中长期发展趋势不会改变，但对公司来说，海外业务增长的同时，业务及收入结构或许难免会出现变化。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099917.html","is_publish_highlight":true,"gpt_icon":1},{"id":"2425053485","title":"港股收评：V型反弹！恒生科技指数跌0.29%，CXO、中海油服遭重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2425053485","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2425053485?lang=zh_cn&edition=full","pubTime":"2024-04-05 16:51","pubTimestamp":1712307060,"startTime":"0","endTime":"0","summary":"朗廷-SS因有望私有化退市，暴涨41%","market":"sg","thumbnail":"https://img3.gelonghui.com/442f4-225f5f62-62e8-4a54-8c80-004f29e3b51c.png","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/442f4-225f5f62-62e8-4a54-8c80-004f29e3b51c.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/716101","is_publish_highlight":false,"gpt_icon":0},{"id":"2420267590","title":"港股午评：恒生科技指数跌1.77% 新能源汽车、CXO概念领跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2420267590","media":"东方财富Choice...","top":-1,"share":"https://www.laohu8.com/m/news/2420267590?lang=zh_cn&edition=full","pubTime":"2024-03-19 12:06","pubTimestamp":1710821195,"startTime":"0","endTime":"0","summary":"【港股午评：恒生科技指数跌1.77% 新能源汽车、CXO概念领跌】港股早盘指数低位震荡，恒生指数跌1.11%，报收16550.9点；恒生科技指数跌1.77%，报收3530.44点。板块方面，猪肉股、百货业概念股领涨；新能源汽车概念股、CXO概念股领跌。热门个股方面，药明康德跌超6%，优必选涨超3%，理想汽车跌超9%，药明生物、小鹏汽车跌超4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1353,202403193016490454.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2419916769","title":"【券商聚焦】招银国际料中国主要CXO公司最早在2024年下半年重新进入业绩加速通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2419916769","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2419916769?lang=zh_cn&edition=full","pubTime":"2024-03-15 13:57","pubTimestamp":1710482239,"startTime":"0","endTime":"0","summary":"该行预计，从融资改善到CXO业绩反弹，将经历一定的时间周期，而2024年下半年全球CXO行业或将迎来需求周期的向上拐点。中国CXO公司的这一轮业绩减速时间点相比海外同行滞后约2至4个季度，主要可能是由于新冠订单节奏的影响。考虑到业绩基数的影响以及中国融资复苏节奏或将慢于海外，该行预计中国主要CXO公司将最早在2024年下半年重新进入业绩加速通道。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200908/ZjFkNmRhNDdmNGNlNWE2NWI4ZjM1ZDNmNTg4YjM5OTg4NDI0NTU0Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/ZjFkNmRhNDdmNGNlNWE2NWI4ZjM1ZDNmNTg4YjM5OTg4NDI0NTU0Nw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1933397","is_publish_highlight":false,"gpt_icon":0},{"id":"2419700996","title":"快讯：港股三大指数低开低走 科网股、CXO概念股、汽车股跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2419700996","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2419700996?lang=zh_cn&edition=full","pubTime":"2024-03-15 11:01","pubTimestamp":1710471660,"startTime":"0","endTime":"0","summary":"　　3月15日消息，今日港股三大指数低开低走，截至发稿，恒生指数跌2.03%，报16618.18点，恒生科技指数跌2.86%，国企指数跌2.31%。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-03-15/doc-inankiew6976492.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-03-15/doc-inankiew6976492.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2406288148","title":"【券商聚焦】交银国际削金斯瑞(01548)目标价3%至27.6港元 指当前CXO板块投资情绪仍未明显恢复","url":"https://stock-news.laohu8.com/highlight/detail?id=2406288148","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2406288148?lang=zh_cn&edition=full","pubTime":"2024-01-25 09:10","pubTimestamp":1706145041,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发研报指，金斯瑞 子公司传奇生物的合作伙伴强生于今日盘前公布4Q23业绩，其中cilta-cel录得销售1.59亿美元的销售额，符合该行此前的预期。该行认为：1）当前港股CXO板块的投资情绪仍未明显恢复，相比传统生物大分子，GCT外包服务的订单增长前景和长期景气度能见度强，当前存在较大预期差；2）传奇生物当前111亿美元的估值和cilta-cel的适应症拓展、销售放量预期仍未完全反映在金斯瑞的股价中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012509111081e198be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012509111081e198be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404378178","title":"【券商聚焦】招银国际削药明生物(02269)目标价11.22% 指海外CXO同行对行业趋势仍持谨慎态度","url":"https://stock-news.laohu8.com/highlight/detail?id=2404378178","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2404378178?lang=zh_cn&edition=full","pubTime":"2024-01-18 14:49","pubTimestamp":1705560545,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际发研报指，药明生物 更新近期业务进展，23年全年新增项目132个，基本维持疫情期间的水平，管理层预计2Q24开始业务将持续向好。另外，海外CXO同行对行业趋势仍持谨慎态度。该行维持“买入”评级，目标价由44.66港元下调11.22%至39.65港元。该行预计药明生物2023E/24E/25E收入增速为10.2%/14.5%/29.0%，经调整归母净利润增速为-6.0%/13.5%/27.8%，对应现阶段股价的FY24E市盈率分别为25/22/17倍。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200915/YWJkMTExMDAwMDkzNTUyODE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/YWJkMTExMDAwMDkzNTUyODE=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1930055","is_publish_highlight":false,"gpt_icon":0},{"id":"2404710348","title":"港股午评：恒生科技指数跌3.87%，CXO、一体化压铸概念领跌，小鹏汽车跌近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404710348","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2404710348?lang=zh_cn&edition=full","pubTime":"2024-01-17 12:01","pubTimestamp":1705464070,"startTime":"0","endTime":"0","summary":"1月17日，港股半天下来，指数持续跳水，恒生指数跌2.81%，报收15419.68点；恒生科技指数跌3.87%，报收3197.25点。板块方面，虚拟现实概念股、殡葬股领涨；CXO概念股、一体化压铸概念股领跌。热门个股方面，小鹏汽车跌近9%，美团跌超5%，小米集团跌超4%，东方甄选跌超3%，腾讯控股跌近3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401171201107a3bd22d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401171201107a3bd22d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402441841","title":"股价从闪崩23%到高开15%！药明生物业绩指引反转带飞CXO板块 2023年新增132个项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2402441841","media":"时代周报","top":-1,"share":"https://www.laohu8.com/m/news/2402441841?lang=zh_cn&edition=full","pubTime":"2024-01-11 17:41","pubTimestamp":1704966117,"startTime":"0","endTime":"0","summary":"药明生物（2269.HK）一份“PPT”再次搅动了CXO（医药外包）资本市场的敏感神经。1月10日晚，药明生物发布2024年度摩根大通医疗健康大会简报，称公司的业务及财务状况依然强劲，于2023年新增132个项目，项目总数达到698个（其中包括9个III期及商业化“赢得分子”项目，以及24个CMO项目）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202401112959186130.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.concho.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Concho Resources Inc.成立于2006年2月22日，是一家于2006年2月在特拉华州注册成立的公司，是一家独立的石油和天然气公司，从事石油和天然气资产的收购、开发、勘探和生产。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.054246},{"month":2,"riseRate":0.384615,"avgChangeRate":-0.002949},{"month":3,"riseRate":0.692308,"avgChangeRate":0.024071},{"month":4,"riseRate":0.769231,"avgChangeRate":0.069872},{"month":5,"riseRate":0.384615,"avgChangeRate":-0.030229},{"month":6,"riseRate":0.461538,"avgChangeRate":0.004495},{"month":7,"riseRate":0.692308,"avgChangeRate":0.012949},{"month":8,"riseRate":0.461538,"avgChangeRate":-0.02419},{"month":9,"riseRate":0.571429,"avgChangeRate":0.015298},{"month":10,"riseRate":0.5,"avgChangeRate":0.017047},{"month":11,"riseRate":0.571429,"avgChangeRate":0.047858},{"month":12,"riseRate":0.642857,"avgChangeRate":0.007299}],"exchange":"NYSE","name":"康休","nameEN":"Concho Resources"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康休(CXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康休(CXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康休,CXO,康休股票,康休股票老虎,康休股票老虎国际,康休行情,康休股票行情,康休股价,康休股市,康休股票价格,康休股票交易,康休股票购买,康休股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康休(CXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康休(CXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}